Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
2.
Dev Growth Differ ; 48(3): 177-88, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16573735

ABSTRACT

Peroxisome proliferator-activated receptor gamma (PPARgamma) plays a central role in adipocyte and macrophage differentiation. Pioglitazone (Actos, AD4833), an antidiabetic drug, and 15-deoxy-Delta(12,14)-prostaglandin J2 (PGJ2) have recently been identified as synthetic and natural ligands for PPARgamma, respectively. In this study, we examined the effects of PPARgamma ligands on differentiation and lipogenesis in promyelocytic leukemia NB4 cells, in which PPARgamma protein was expressed and ligand-stimulated PPARgamma-specific transcription of adipocyte fatty-acid binding protein was confirmed. Treatment with PPARgamma ligand (AD4833 or PGJ2) alone markedly suppressed proliferation but did not induce differentiation. The combined treatment of the cells with PPARgamma ligand and all-trans retinoic acid (ATRA) synergistically induced myelocytic differentiation, as determined by nitroblue tetrazolium reducing ability and cell morphology. During these processes of differentiation, we observed marked accumulation of lipid droplets in the cytoplasm. The cellular triacylglycerol levels increased 2.7-fold after treatment with the inducers. Simultaneously, BODIPY-fatty acid was incorporated into the cytosol and concentrated in lipid droplets. The biosynthesis of triacylglycerol-containing BODIPY-fatty acids was increased twofold in differentiated cells. These findings clearly demonstrate that treatment with PPARgamma ligands not only induced differentiation but also stimulated lipogenesis in NB4 cells, indicating a close association between differentiation and lipogenesis in PPARgamma-stimulated human myeloid cells.


Subject(s)
Lipids/physiology , Myeloid Cells/physiology , PPAR gamma/physiology , Prostaglandin D2/analogs & derivatives , Thiazolidinediones/pharmacology , Adipocytes/drug effects , Adipocytes/metabolism , Anilides/pharmacology , Benzoates/pharmacology , Biphenyl Compounds/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Line, Tumor , Cell Proliferation/drug effects , Fatty Acid-Binding Proteins/drug effects , Fatty Acid-Binding Proteins/metabolism , Humans , Ligands , Myeloid Cells/cytology , Myeloid Cells/drug effects , PPAR gamma/drug effects , Pioglitazone , Prostaglandin D2/pharmacology , Tretinoin/pharmacology , Triglycerides/metabolism , Tumor Cells, Cultured , Up-Regulation
3.
Am J Physiol Endocrinol Metab ; 289(3): E419-28, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15827065

ABSTRACT

Insulin/IGF-I-dependent signals play important roles for the regulation of proliferation, differentiation, metabolism, and autophagy in various cells, including hematopoietic cells. Although the early protein kinase activation cascade has been intensively studied, the whole picture of intracellular signaling events has not yet been clarified. To identify novel downstream effectors of insulin-dependent signals in relatively early phases, we performed high-resolution two-dimensional electrophoresis (2-DE)-based proteomic analysis using human hematopoietic cells 1 h after insulin stimulation. We identified SRp20, a splicing factor, and CLIC1, an intracellular chloride ion channel, as novel downstream effectors besides previously reported effectors of Rho-guanine nucleotide dissociation inhibitor 2 and glutathione S-transferase-pi. Reduction in SRp20 was confirmed by one-dimensional Western blotting. Moreover, MG-132, a proteasome inhibitor, prevented this reduction. By contrast, upregulation of CLIC1 was not observed in one-dimensional Western blotting, unlike the 2-DE results. As hydrophilic proteins were predominantly recovered in 2-DE, the discrepancy between the 1-DE and 2-DE results may indicate a certain qualitative change of the protein. Indeed, the nuclear localization pattern of CLIC1 was remarkably changed by insulin stimulation. Thus insulin induces the proteasome-dependent degradation of SRp20 as well as the subnuclear relocalization of CLIC1.


Subject(s)
Chloride Channels/metabolism , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , RNA-Binding Proteins/metabolism , Signal Transduction/physiology , Amino Acid Sequence , Chloride Channels/analysis , Chloride Channels/chemistry , Electrophoresis, Gel, Two-Dimensional , HL-60 Cells , Humans , Molecular Sequence Data , Proteomics , RNA-Binding Proteins/analysis , RNA-Binding Proteins/chemistry , Serine-Arginine Splicing Factors , Signal Transduction/drug effects , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
4.
Cell Struct Funct ; 28(5): 487-93, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14745140

ABSTRACT

All trans retinoic acid (ATRA), a differentiation inducer for human myeloid NB4 cells, induced accumulation of lipid droplet as determined by positivity of Nile Red and Oil Red O in this cell line. Granulocyte colony-stimulating factor (G-CSF), although not having detectable effect by itself, exerted the additive effects on lipid droplet formation in NB4 cells when combined with ATRA. mRNA analysis for peroxisome proliferator-activated receptors (PPARs) revealed the initial transient downregulation followed by upregulation of the transcript for PPARgamma2, a master molecule for adipogenesis, and upregulation of PPARalpha. BADGE, a synthetic antagonist for PPARgamma, potently inhibited lipid droplet formation in NB4 cells stimulated by ATRA and/or G-CSF, but not the functional differentiation of the cells by ATRA and/or G-CSF. These results suggest that ATRA and G-CSF induce lipid droplet formation via certain PPARgamma-mediated specific mechanisms in human myeloid NB4 cells during functional differentiation.


Subject(s)
Antineoplastic Agents/pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Lipid Metabolism , Myeloid Cells/drug effects , Myeloid Cells/physiology , Receptors, Cytoplasmic and Nuclear/metabolism , Transcription Factors/metabolism , Tretinoin/pharmacology , Cell Differentiation/physiology , Cell Line , Gene Expression Regulation , Humans , Inclusion Bodies/chemistry , Inclusion Bodies/metabolism , Myeloid Cells/cytology , Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors , Receptors, Cytoplasmic and Nuclear/genetics , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics
6.
Asia Pac J Clin Nutr ; 11(2): 112-6, 2002.
Article in English | MEDLINE | ID: mdl-12074176

ABSTRACT

In Vietnam, increasing fat consumption is a trend recognized recently in urban areas. To obtain a reasonable nutrition status and prevent cardiovascular disease (CVD), it is necessary to obtain information on habitual fat intake and biochemical parameters as risk factors for CVD in Vietnamese populations. Therefore, from the analysis of serum fatty acid composition, fat consumption patterns in Vietnamese populations in South Vietnam, with different incomes, are discussed in this study. In addition, some risk factors for premature CVD, serum lipoprotein (a) and apolipoprotein concentrations are also assessed in these Vietnamese populations. The study was carried out in men and women aged 40-59 in three different districts: urban (n = 100), suburban (n = 98) and rural (n = 98). The results of serum fatty acid composition analysis reflected differences in quality fat intake among the three populations. The urban population was estimated to consume more vegetable oil but less fish than their rural counterparts. Although serum lipoprotein (a) and apolipoprotein B levels were below the ranges associated with atherogenesis, ongoing attention to dietary fat intake for the prevention of CVD in Vietnamese populations is required.


Subject(s)
Apolipoproteins/blood , Cardiovascular Diseases/blood , Cardiovascular Diseases/etiology , Fatty Acids/blood , Lipoprotein(a)/blood , Adult , Body Mass Index , Female , Humans , Male , Middle Aged , Risk Factors , Rural Population/statistics & numerical data , Suburban Population/statistics & numerical data , Urban Population/statistics & numerical data , Vietnam
7.
Zoolog Sci ; 19(1): 7-13, 2002 Jan.
Article in English | MEDLINE | ID: mdl-12025407

ABSTRACT

Dolichyl monophosphate (Dol-P) is involved in the attachment of carbohydrate chains to proteins in the formation of N-linked glycoprotein. We found that this compound induces apoptosis in human leukemia U937 cells. During this apoptotic execution, the increase of plasma membrane fluidity (5-20 min), reduction in mitochondrial transmembrane potential (delta psi m) and translocation of apoptosis-inducing factor (1-3 hr), caspase-3-like protease activation (2-4 hr), chromatin condensation and DNA ladder formation (3-4 hr) were observed successively. In this study, we examined mitochondrial morphological changes by electron microscopy and delta psi m by JC-1 from immediately after treatment of Dol-P. After 5 min of treatment, we observed clearly that mitochondrial cristae began to be disrupted ultrastructurally and almost all the cristae were disintegrated after 1 hr of treatment. The delta psi m of Dol-P treated cells was reduced to 34% as compared with that of control cells immediately after treatment and was quartered within 1 hr. The reduction in delta psi m was not inhibited by cyclosporin A, N-acetyl-L-cysteine and vitamin E. These results indicate that mitochondrial disruption is one of the first triggering events of Dol-P-induced apoptosis.


Subject(s)
Apoptosis/drug effects , Dolichol Phosphates/pharmacology , Mitochondria/drug effects , Mitochondria/physiology , Humans , Logistic Models , Membrane Fluidity/drug effects , Membrane Potentials/drug effects , Mitochondria/metabolism , Mitochondria/ultrastructure , Time Factors , U937 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...